Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $1000.0.

  • STRATA Skin Sciences' Change in Accured Expenses fell 9994.53% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 14154.82%. This contributed to the annual value of $2.3 million for FY2024, which is 125025.38% up from last year.
  • STRATA Skin Sciences' Change in Accured Expenses amounted to $1000.0 in Q3 2025, which was down 9994.53% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Change in Accured Expenses ranged from a high of $1.8 million in Q3 2024 and a low of -$1.4 million during Q2 2025
  • Moreover, its 5-year median value for Change in Accured Expenses was $169000.0 (2025), whereas its average is $146157.9.
  • Per our database at Business Quant, STRATA Skin Sciences' Change in Accured Expenses soared by 694166.67% in 2021 and then plummeted by 154400.0% in 2023.
  • Over the past 5 years, STRATA Skin Sciences' Change in Accured Expenses (Quarter) stood at $821000.0 in 2021, then tumbled by 39.59% to $496000.0 in 2022, then dropped by 16.53% to $414000.0 in 2023, then crashed by 64.25% to $148000.0 in 2024, then crashed by 99.32% to $1000.0 in 2025.
  • Its Change in Accured Expenses stands at $1000.0 for Q3 2025, versus -$1.4 million for Q2 2025 and $169000.0 for Q1 2025.